Choosing Wisely: A Comprehensive Comparison of Umbilical Cord and Adipose Stem Cells for Regenerative Therapies
The choice between umbilical cord and adipose stem cells depends on various factors however the higher safety profile associated with using one’s own adipose stem cells underscores its appeal in the realm of regenerative medicine.
Which of my own stem cell types should I use?
The unique advantages of adipose stem cells positions them as a front runner in the pursuit of effective regenerative treatments.
Unlocking the Future of Health: The Case for Early Adipose Stem Cell Storage, No Matter Your Age
The decision to store adipose stem cells is a proactive and visionary step towards securing one’s future health, irrespective of age.
Bank Your Medical Future
StemInsureTM provides the opportunity to preserve your stem cells, ensuring access to your younger and healthier self when facing future inflammatory conditions.
PSC Knee Osteoarthritis Stem Cell Research Results
Personalized Stem Cells has completed the first ever FDA-approved clinical trial of GMP lab manufactured adipose derived stem cells for patients with knee osteoarthritis.
Investing in PSC Unlocks Tax Benefits
PSC investors benefit from Section 1202 of the Internal Revenue Code which offers a significant tax incentive.
How Epigenetics Shapes the Journey of Aging
Aging is a universal part of life, but have you ever wondered why some people seem to age more gracefully than others? The answer lies hidden within our genes, and a fascinating field of science known as epigenetics is shedding light on this timeless mystery.
Growth Factors: The Benefits and Risks
Growth factors have the potential to be a useful tool in regenerative medicine but more studies are needed to ensure their safe and effective use.
Exosomes Early Promise
While exosome therapy is a burgeoning field, there are currently no FDA approved exosome treatments as more studies are needed to confirm the safety and efficacy of such products.
Expanded Access
Expanded access is an FDA program that under certain conditions allows the use of an investigational new drug (IND) to treat a patient with a serious or life-threatening disease outside of a clinical trial.